Biotech financing update: March to May 2019

Imperial, the leading global science university, is achieving a major step up in its life sciences capacity at its White City Deep Tech Campus through a major new joint venture with Bruntwood SciTech.

Novel therapeutics to address unmet clinical need for pneumonias caused by drug-resistant Escherichia coli and Klebsiella pneumoniae; PACE provides funding and support for innovative, high value, high risk, early phase drug discovery and diagnostic projects

Dr Mahony will work with the UK Government to champion investment into the UK’s innovative life sciences and biotech sector, including playing a key role in the ongoing pension reforms led by Chancellor Rachel Reeves MP.

Pension reform unlocks cash for UK life sciences, London Life Sciences Week and #bioProcessUK are here.

Scancell announces strengthening of leadership team as it closes on value-generating inflection points

New data shows investing in life sciences produces great returns, London Life Sciences Week and #bioProcessUK are nearly here.